Image de couverture de livre

Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Stephanie Fetzko, Abha A. Gupta, Bhuvana A. Setty, Mary Wedekind Malone, Jeremy Schraw, Philip J. Lupo, Heidi Russell, Lauren Nicholls, David Walterhouse, Douglas S. Hawkins, M. Fatih Okcu
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Pediatric Blood & Cancer
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Correction to “Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma”
Publié: (2025)

Paraneoplastic Ichthyosis Preceding the Diagnosis of Gluteal Rhabdomyosarcoma at Initial Presentation and Relapse
par: Swetha Palla, et autres
Publié: (2025)

Rhabdomyosarcoma Surgical Update
par: Timothy Rogers, et autres
Publié: (2025)

Transcriptomic Profiling of Relapsed Rhabdomyosarcoma: Pre‐ and Post‐Treatment Tissue Analysis Reveals Molecular Characteristics of Treatment Failure
par: Andrew Muskara, et autres
Publié: (2025)

Intermediate Risk Rhabdomyosarcoma in Very Young Children (Less Than or Equal to 24 Months) Treated on the Prior Children's Oncology Group Protocol ARST1431
par: Katrina Winsnes, et autres
Publié: (2026)

Barriers to long‐term follow‐up in pediatric Hodgkin lymphoma survivors
par: Hailey Tinsley, et autres
Publié: (2024)

Treatment and Outcomes of Children and Adults With Rhabdomyosarcoma in Rwanda
par: Oscar Nsanzimana, et autres
Publié: (2026)

Results of a Phase II Trial for Intermediate‐Risk Rhabdomyosarcoma Treatment Protocol JRS‐I: A Report From the Japan Rhabdomyosarcoma Study Group
par: Atsushi Kikuta, et autres
Publié: (2025)

Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: A Report From the Children's Oncology Group
par: Jamie M. Aye, et autres
Publié: (2025)

Indications and Outcomes for Tracheostomies in Pediatric Oncology Patients—A Single Center Study
par: Jonathan Pan, et autres
Publié: (2024)

The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience
par: Thomas J. Jackson, et autres
Publié: (2026)

Clinicopathological Analysis of a European Cohort of MYOD1 Mutant Rhabdomyosarcomas in Children and Young Adults
par: Julia C. Chisholm, et autres
Publié: (2024)

Focal Nodular Hyperplasia (FNH)/FNH‐Like Lesions: An Important Potential Mimic of Relapsed Malignancy in Pediatric Cancer Patients
par: Jonathan Abrams, et autres
Publié: (2025)

Increased Risk of Sarcomas in Children With Congenital Anomalies: Findings From the Genetic Overlap Between Anomalies and Cancer in Kids (GOBACK) Registry Linkage Study
par: Russ Wolters, et autres
Publié: (2026)

Docetaxel‐Induced Myositis in a 16‐Year‐Old Male With Rhabdomyosarcoma: Case Report and Literature Review
par: Rohaum Hamidi, et autres
Publié: (2026)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pediatric Abdominal Rhabdomyosarcoma: Experience of a Reference Pediatric Oncosurgical Center
par: Cristian Urla, et autres
Publié: (2025)

Late Events Occurring After 5 Years in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group
par: Sara Kreimer, et autres
Publié: (2024)

Local Control and Toxicity Outcomes After Stereotactic Body Radiation Therapy for Metastatic Osteosarcoma in Pediatric Patients
par: Sohil Reddy, et autres
Publié: (2025)

Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 Study
par: Daniel A. Morgenstern, et autres
Publié: (2026)

The evidence is mounting: Insurance coverage disruptions lead to worse outcomes among children diagnosed with cancer
par: Philip J. Lupo, et autres
Publié: (2024)

Local Control of Bladder/Prostate Rhabdomyosarcoma: An Expert Consensus Guideline From the International Soft Tissue Sarcoma Consortium (INSTRuCT)
par: Daniel J. Indelicato, et autres
Publié: (2026)

Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma
par: Molly Mack, et autres
Publié: (2026)

Management of Pediatric and Adolescent Rhabdomyosarcoma of the Chest Wall: An Expert Consensus Opinion From the International Soft Tissue Sarcoma Consortium (INSTRuCT)
par: Andreas Schmidt, et autres
Publié: (2025)

Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
par: Andrew E. Place, et autres
Publié: (2025)

Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia
par: Seth E. Karol, et autres
Publié: (2025)

Trametinib Monotherapy in the Treatment of Pediatric Refractory/Relapse Langerhans Cell Histiocytosis
par: Wenqian Wang, et autres
Publié: (2026)

Relapse and survival after relapse among children with cancer in Denmark: 2001–2021
par: Mie Mølgaard Andersen, et autres
Publié: (2024)

CPX‐351 in High‐Risk Relapsed Pediatric Acute Leukemia: Real‐World Phase 1 Data Establishing the FDA‐Approved Dose
par: Jonathan D. Bender, et autres
Publié: (2026)

Correction to “Outcomes of Relapsed Favorable‐Histology Wilms Tumor in Non‐Clinical Trial Setting”
Publié: (2025)

Gemcitabine, Docetaxel, Melphalan, Carboplatin as Part of Sequential Cycles of High‐Dose Chemotherapy With Autologous Hematopoietic Stem‐Cell Rescue for Multiply Relapsed/Refractory Pediatric Germ Cell Tumors
par: Maria Frost, et autres
Publié: (2026)

Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives
par: Kathryn S. Sutton, et autres
Publié: (2025)

Anti‐Tumor Activity of Paclitaxel‐Containing Regimens in Recurrent/Refractory Wilms Tumor
par: Alissa Groisser, et autres
Publié: (2025)

Retrospective Review of Spinal Cord Compression Occurrences and Management in Children With Relapsed, Progressing, or Refractory Malignancies
par: Adi Nitzan‐Luques, et autres
Publié: (2024)

Increasing Paternal Age Associated With Elevated Risk of De Novo Mutations in Offspring Diagnosed With Sporadic Bilateral Retinoblastoma
par: Maral Adel Fahmideh, et autres
Publié: (2025)

Children and Adolescents With Localised Non‐Rhabdomyosarcoma Soft Tissue Sarcoma: Results of the CWS‐96 and CWS‐2002P Prospective Trials With Reclassification of the Trial Data Incorporating the Recent Soft Tissue Sarcoma Registry
par: Amadeus T. Heinz, et autres
Publié: (2025)

Treatment of Pediatric, Adolescent, and Young Adult Patients With Fusion‐Positive Alveolar Rhabdomyosarcoma Infiltrating Regional Lymph Nodes in the European CWS‐2002P and RMS 2005 Studies and the Soft Tissue Sarcoma Registry
par: Amadeus T. Heinz, et autres
Publié: (2024)

Intestinal Low‐Dose Radiation to Overcome PD‐1 Resistance in Pediatric Relapsed/Refractory Hodgkin Lymphoma
par: Shubham Sahni, et autres
Publié: (2026)

Impact of Centres With Different Patient Volume on Diagnostic Process, Therapeutic Strategy and Outcome in Patients With Localised Rhabdomyosarcoma: A Report From the European paediatric Soft tissue sarcoma Study Group (E p SSG)
par: Maria Carmen Affinita, et autres
Publié: (2026)

Pazopanib Combined With Vincristine and Irinotecan in Relapsed Wilms Tumor: Encouraging Outcomes in a Heavily Pretreated Pediatric Cohort
par: Maria Debora De Pasquale, et autres
Publié: (2026)

Near Complete Response With Trastuzumab Deruxtecan in a Teenager With Relapsing Metastatic Desmoplastic Small Round Cell Tumor
par: Caroline Donze, et autres
Publié: (2025)